- Filed
- May 27, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 6.23B sh |
| Capex | Q1 2026 · Mar 31, 2026 | $25.71K |
| Capex | Q1 2026 · Mar 31, 2025 | $4.66K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$67.76K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$103.74K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.4K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $11.62K |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2026 | $242.7M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2025 | $242.77M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $241.11M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.06M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.05M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.09M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.06M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $94.56K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $145.98K |
| Total Assets restated | Q1 2026 · Mar 31, 2026 | $247.8M |
| Total Assets restated | Q1 2026 · Dec 31, 2025 | $247.83M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$146.9K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$81.69K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$139.16K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$81.69K |